110 related articles for article (PubMed ID: 2793598)
1. Synthesis and antibacterial activity of 9-O-[(2-methoxyethoxy)methyl]-oximes of tylosin and demycarosyltylosin.
Ruggeri C; Laborde MA; Dessinges A; Ming L; Olesker A; Lukacs G
J Antibiot (Tokyo); 1989 Sep; 42(9):1443-5. PubMed ID: 2793598
[No Abstract] [Full Text] [Related]
2. Antimalarial C-9 oxime derivatives from desmycosin, produced by click chemistry.
Tsutsui A; Hirose T; Ishiyama A; Iwatsuki M; Yokota A; Maruyama H; Matsui H; Otoguro K; Hanaki H; Omura S; Sunazuka T
J Antibiot (Tokyo); 2013 Mar; 66(3):191-4. PubMed ID: 23232930
[No Abstract] [Full Text] [Related]
3. Erythromycin A oxime 11,12-carbonate and its oxime ethers.
Brain EG; Forrest AK; Hunt E; Shillingford C; Wilson JM
J Antibiot (Tokyo); 1989 Dec; 42(12):1817-22. PubMed ID: 2621163
[TBL] [Abstract][Full Text] [Related]
4. 10,11,12,13-Tetrahydro derivatives of tylosin. II. Synthesis, antibacterial activity and tissue of 4'-deoxy-10,11,12,13-tetrahydrodesmycosin.
Narandja A; Kelneríc Z; Kolacny-Babíc L; Djokić S
J Antibiot (Tokyo); 1995 Mar; 48(3):248-53. PubMed ID: 7730160
[TBL] [Abstract][Full Text] [Related]
5. New amidino-benzimidazolyl derivatives of tylosin and desmycosin.
Hranjec M; Starcević K; Zamola B; Mutak S; Derek M; Karminski-Zamola G
J Antibiot (Tokyo); 2002 Mar; 55(3):308-14. PubMed ID: 12014447
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and structure-activity relationships of 6-O-arylpropargyl diazalides with potent activity against multidrug-resistant Streptococcus pneumoniae.
Yong H; Gu YG; Clark RF; Marron T; Ma Z; Soni N; Stone GG; Nilius AM; Marsh K; Djuric SW
Bioorg Med Chem Lett; 2005 May; 15(10):2653-8. PubMed ID: 15863336
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 3-deoxy-3,4-didehydro derivatives of 5-O-mycaminosyltylonolide, 5-O-(4-deoxymycaminosyl) tylonolide, and desmycosin.
Kageyama S; Tsuchiya T; Umezawa S
J Antibiot (Tokyo); 1993 Aug; 46(8):1265-78. PubMed ID: 8407589
[TBL] [Abstract][Full Text] [Related]
8. Electrochemical reduction of desmycosin, structure investigation and antibacterial evaluation of the resulting products.
Iveković D; Lopotar N; Brajsa K; Mandić Z
Eur J Pharm Sci; 2003 Apr; 18(5):323-8. PubMed ID: 12694884
[TBL] [Abstract][Full Text] [Related]
9. 5-O-Mycaminosyltylonolide antibacterial derivatives: design, synthesis and bioactivity.
Sugawara A; Maruyama H; Shibusawa S; Matsui H; Hirose T; Tsutsui A; Froyman R; Ludwig C; Koebberling J; Hanaki H; Kleefeld G; Ōmura S; Sunazuka T
J Antibiot (Tokyo); 2017 Jul; 70(8):878-887. PubMed ID: 28559578
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimicrobial activity of 3-hydroxyimino-5-methyl-2-hexanone(HIMH) and its dioxime derivative.
Patil VR; Donde KJ; Jadhav SB; Malve SP
Acta Pol Pharm; 2002; 59(3):223-5. PubMed ID: 12230250
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antibacterial activity of a novel class of 4'-substituted 16-membered ring macrolides derived from tylosin.
Phan LT; Jian T; Chen Z; Qiu YL; Wang Z; Beach T; Polemeropoulos A; Or YS
J Med Chem; 2004 Jun; 47(12):2965-8. PubMed ID: 15163176
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2-methyl 16-membered macrolide derived from tylosin.
Terui Y; Kinoshita K; Kaneda Y; Akashi T; Hamaguchi T; Kawashima A
J Antibiot (Tokyo); 2006 Feb; 59(2):98-104. PubMed ID: 16629410
[TBL] [Abstract][Full Text] [Related]
13. New rifamycins. II. Synthesis and biological activity of oximes, hydrazones, and semicarbazones of 3-N-(piperidin-4-one)rifamycin S.
Marsili L; Franceschi G; Galliani C; Sanfilippo A; Vigevani A
Farmaco Sci; 1982 Dec; 37(12):781-6. PubMed ID: 7152013
[No Abstract] [Full Text] [Related]
14. New derivatives of tylosin. IV. Dihydro and tetrahydro desmycosin oximes.
Naranda A; Lopotar N
J Antibiot (Tokyo); 1999 Jan; 52(1):68-70. PubMed ID: 10092201
[No Abstract] [Full Text] [Related]
15. Studies on pyrazine derivatives. XLVII. Synthesis and antibacterial activity of novel pyrazine derivatives with amidoxime moiety.
Gobis K; Foks H; Kedzia A; Wierzchowska M; Kwapisz E; Zwolska Z; Augustynowicz-Kopeć E
Acta Pol Pharm; 2006; 63(1):39-45. PubMed ID: 17515328
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel tylosin analogues generated by a wblA disruption mutant of Streptomyces ansochromogenes.
Lu C; Liao G; Zhang J; Tan H
Microb Cell Fact; 2015 Nov; 14():173. PubMed ID: 26525981
[TBL] [Abstract][Full Text] [Related]
17. Multicomponent synthesis of α-acylamino and α-acyloxy amide derivatives of desmycosin and their activity against gram-negative bacteria.
Budragchaa T; Westermann B; Wessjohann LA
Bioorg Med Chem; 2019 Aug; 27(15):3237-3247. PubMed ID: 31229422
[TBL] [Abstract][Full Text] [Related]
18. Syntheses and antimicrobial activities of 9-O-acyl derivatives of tylosin and demycarosyltylosin.
Tsuzuki K; Matsubara H; Nakagawa A; Omura S
J Antibiot (Tokyo); 1986 Dec; 39(12):1784-7. PubMed ID: 3818453
[No Abstract] [Full Text] [Related]
19. Synthesis and in vitro antimicrobial activity of 3-keto 16-membered macrolides derived from tylosin.
Creemer LC; Toth JE; Kirst HA
J Antibiot (Tokyo); 2002 Apr; 55(4):427-36. PubMed ID: 12061552
[TBL] [Abstract][Full Text] [Related]
20. Semisynthetic macrolide antibacterials derived from tylosin. Synthesis and structure-activity relationships of novel desmycosin analogues.
Mutak S; Marsić N; Kramarić MD; Pavlović D
J Med Chem; 2004 Jan; 47(2):411-31. PubMed ID: 14711312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
